About RheaVita
RheaVita is a company based in Ghent (Belgium) founded in 2018 by Jos Corver and Thomas De Beer.. RheaVita has raised $3.06 million across 1 funding round from investors including PMV and Novalis Biotech. The company has 4 employees as of December 31, 2022. RheaVita offers products and services including RheaLyo Mono, RheaLyo GMP-Flex, Feasibility Studies, Formulation Advice, and Process Development. RheaVita operates in a competitive market with competitors including Limula, PBS Biotech, m2p-labs, Membio and Ark Biotech, among others.
- Headquarter Ghent, Belgium
- Employees 4 as on 31 Dec, 2022
- Founders Jos Corver, Thomas De Beer
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rheavita
-
Annual Revenue
-
Net Profit
$-133 K (USD)67as on Dec 31, 2022
-
EBITDA
$-578.63 K (USD)7as on Dec 31, 2022
-
Total Equity Funding
$3.06 M (USD)
in 1 rounds
-
Latest Funding Round
$3.06 M (USD), Series A
Jun 02, 2021
-
Investors
PMV
& 1 more
-
Employee Count
4
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RheaVita
RheaVita offers a comprehensive portfolio of products and services, including RheaLyo Mono, RheaLyo GMP-Flex, Feasibility Studies, Formulation Advice, and Process Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
R&D tool for continuous lyophilisation in biopharmaceutical applications.
GMP-compliant system for scalable freeze-drying processes.
Evaluates viability of freeze-drying for pharmaceutical needs.
Provides guidance on product formulation for lyophilisation.
Assists in developing efficient freeze-drying procedures.
Unlock access to complete
Unlock access to complete
Funding Insights of RheaVita
RheaVita has successfully raised a total of $3.06M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.06 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $3.1M
-
First Round
First Round
(02 Jun 2021)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Series A - RheaVita | Valuation | Novalis Biotech , PMV |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in RheaVita
RheaVita has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include PMV and Novalis Biotech. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital investment is provided in life sciences.
|
Founded Year | Domain | Location | |
|
Private debt funds are managed across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by RheaVita
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - RheaVita
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rheavita Comparisons
Competitors of RheaVita
RheaVita operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Limula, PBS Biotech, m2p-labs, Membio and Ark Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Modular solutions for on-demand cell therapy manufacturing are provided.
|
|
| domain | founded_year | HQ Location |
Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies
|
|
| domain | founded_year | HQ Location |
Micro-bioreactors are provided for screening and bioprocess development.
|
|
| domain | founded_year | HQ Location |
Developer of single-use bioreactors for cell and gene therapies
|
|
| domain | founded_year | HQ Location |
Bioreactors and systems for cultivated meat production are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about RheaVita
When was RheaVita founded?
RheaVita was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Where is RheaVita located?
RheaVita is headquartered in Ghent, Belgium. It is registered at Ghent, East Flanders, Belgium.
Is RheaVita a funded company?
RheaVita is a funded company, having raised a total of $3.06M across 1 funding round to date. The company's 1st funding round was a Series A of $3.06M, raised on Jun 02, 2021.
How many employees does RheaVita have?
As of Dec 31, 2022, the latest employee count at RheaVita is 4.
What does RheaVita do?
RheaVita was founded in 2018 in Ghent, Belgium, focusing on pharmaceutical manufacturing technology. An instrument for continuous freeze-drying is developed to integrate all process steps, including unit operations, into a single production line. Constant infeed of unit doses is enabled, along with simultaneous removal of the dried product, supporting efficient operations in the biopharma sector.
Who are the top competitors of RheaVita?
RheaVita's top competitors include PBS Biotech, m2p-labs and Limula.
What products or services does RheaVita offer?
RheaVita offers RheaLyo Mono, RheaLyo GMP-Flex, Feasibility Studies, Formulation Advice, and Process Development.
Who are RheaVita's investors?
RheaVita has 2 investors. Key investors include PMV, and Novalis Biotech.